Showing results (141-150 of 201) with videos related to

Sort By:
Pageof 21
Bone Marrow Transplantation|January 10, 2001
Donor leukocyte infusions for multiple myelomaM Salama, T Nevill, D Marcellus, et al.
Bone Marrow Transplantation|June 18, 1999
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemiaD Przepiorka, I Khouri, P Thall, et al.
Bone Marrow Transplantation|August 10, 2000
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)B S Andersson, J Gajewski, M Donato, et al.
Breast Cancer Research and Treatment|August 21, 2001
CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapyA R Manhani, R Manhani, H P Soares, et al.
Transplantation|December 27, 1996
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimusD Przepiorka, C Ippoliti, I Khouri, et al.
Bone Marrow Transplantation|January 5, 2016
Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis studyS Afifi, N G Adel, S Devlin, et al.
Blood|December 23, 1999
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host diseaseD Przepiorka, N A Kernan, C Ippoliti, et al.
Blood Cancer Journal|September 18, 2012
Cancer-testis antigen expression and immunogenicity in AL amyloidosisM A Rosenzweig, H Landau, D Seldin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|June 26, 2009
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)S Giralt, E A Stadtmauer, J L Harousseau, et al.
Pageof 21